Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million
The move marks Ipsen’s second acquisition this week after its agreement to take over Kartos Therapeutics, a company developing a drug to treat a rare blood cancer.
Connecting Global Economies
Flash News
Europe defense stocks face rearmament test
Reese Witherspoon's No. 1 Advice for Elle's Lexi Minetree Is Iconic
Mexico’s surging World Cup belief has a high-altitude X factor: The Estadio Azteca
Iran prepares grand funeral for late supreme leader killed on war’s first day
KKR, SK Inc launch Korea’s large renewable energy venture amid AI, chip boom
Vanderpump Rules’ James Kennedy, Pregnant Jordan Meyers Engaged
Is France’s World Cup attack one of the best ever? Is any record safe from Haaland? Day 20 recap
Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million
Raid to relief as US military aids Venezuela after twin earthquakes
Employers who laid off workers for AI are reversing their decisions
Wednesday, July 01, 2026